Smoking Cessation Aids Compared: What Actually Works, Which One Suits You and How to Use It Properly

Here is the number that reframes everything else on this page. Of people who decide to stop smoking and do it on willpower alone, roughly three to five percent are still not smoking a year later.

That figure is not a comment on character. It is a measurement of how thoroughly nicotine rewires the brain, and it is the reason medication exists for this. The question worth asking is not whether to use help but which help, because the options differ from each other by a factor of two or three.

🧠 What nicotine did to the brain

Nicotine reaches the brain within about ten seconds of inhaling and binds to receptors that release dopamine. Repeat that twenty times a day for years and the brain adapts in a specific, measurable way: it grows more of those receptors.

Now there are more receptors than nicotine can keep occupied between cigarettes. Empty ones generate the signal experienced as craving, tension and difficulty concentrating. The next cigarette fills them and the discomfort stops — which is the trap. Most of what smoking delivers after the first year is relief from withdrawal that smoking itself created.

Receptor numbers do fall back towards normal after stopping, over weeks to months. That recovery is what the medication is covering for, and it explains why the hard part has a defined end rather than lasting forever.

⏱️ What the first month actually feels like

Knowing the shape of this in advance changes how people handle it, because the worst point arrives early and then improves.

That last line is worth holding on to. A craving at month four is not evidence of failure and not a sign the addiction is permanent — it is a short wave that passes whether or not anything is done about it.

🏆 What works, ranked honestly

These are the approximate odds of still being smoke-free at six to twelve months, compared against quitting with no help at all.

Two things follow from this table. Medication roughly doubles or triples the chance, and medication combined with some form of support beats medication alone. Nobody has to choose between pharmacology and effort — the two multiply.

💊 Varenicline: how the most effective option works

Chantix (Varenicline) does something neither of the other options can. It binds to the same receptor nicotine uses, but only partially activates it — and while it sits there, nicotine cannot.

That produces two effects at once. Withdrawal is blunted, because the receptor is not empty. And smoking becomes less rewarding, because an inhaled cigarette can no longer reach a receptor already occupied. People frequently describe cigarettes during treatment as pointless rather than forbidden, which is a very different experience from resisting one.

The quit date is usually set for around day 8, though a flexible approach is also accepted, where smoking is reduced over the first weeks and stopped by around week five. A further 12 weeks is sometimes added for people who have stopped successfully, which reduces the chance of relapse.

One historical point matters, because outdated warnings still circulate. Varenicline once carried a boxed warning about psychiatric side effects. A large randomised trial designed specifically to test this, including people with existing mental health conditions, found no significant increase in serious neuropsychiatric events, and the boxed warning was removed in 2016. Mood changes should still be reported, as with any drug acting on the brain, but the drug is not the hazard it was once labelled as.

💊 Bupropion: the right answer for specific people

Zyban (Bupropion 150 mg SR) works differently again. It is an antidepressant by origin, raising dopamine and noradrenaline availability, and it reduces craving and withdrawal through that route rather than by touching nicotine receptors directly.

It is less effective than varenicline on average. It is nonetheless the better choice in two situations, and both come up often:

• 🧠 A history of depression, or low mood that worsens during previous quit attempts. Bupropion treats both problems with one drug
• ⚖️ Strong concern about weight gain. Bupropion measurably delays the weight increase that usually follows stopping, for as long as it is taken. For some people this is the deciding factor in trying at all

It is also the alternative when varenicline is not tolerated.

Insomnia is the most common effect, which is why the second dose goes in the late afternoon rather than at bedtime. Dry mouth, headache and mild restlessness also occur.

⚠️ Who must not take bupropion

Bupropion lowers the threshold at which a seizure can occur. At the recommended dose that risk is small, roughly one in a thousand, but it rises sharply in particular circumstances, and these are absolute rather than cautionary.

• 🚫 Any history of seizures or epilepsy
• 🚫 Current or past bulimia or anorexia nervosa — the electrolyte disturbance in eating disorders raises seizure risk substantially
• 🚫 Stopping heavy alcohol use, benzodiazepines or antiepileptic medication abruptly
• 🚫 An MAOI antidepressant now or within the past 14 days
• ⚠️ Caution with head injury history, a brain tumour, severe liver disease, or other medicines that lower the seizure threshold

⚖️ Choosing between them

A short decision table, since the two drugs are not interchangeable.

🩹 Nicotine replacement, used properly

Nicotine replacement is frequently dismissed because it is familiar and sold next to the chewing gum. Used correctly it performs close to varenicline, and the correct use is specific.

One product is not enough. A patch delivers a steady background level and handles baseline withdrawal, but it cannot respond to a sudden craving. A gum, lozenge, inhalator or spray acts within minutes but does nothing between uses. Using a patch plus one fast-acting form is substantially more effective than either alone, and this is where most unassisted attempts with nicotine replacement go wrong.

The second common error is underdosing and undertreating. Patches are matched to how much is smoked, the fast-acting form is used whenever a craving arrives rather than rationed, and the course runs 8 to 12 weeks rather than a fortnight.

Gum and lozenges also have a technique: chew slowly until the taste becomes peppery, then park it against the cheek and resume when the taste fades. Chewing it like ordinary gum sends nicotine into the stomach, where it causes hiccups and nausea and does very little else. Acidic drinks such as coffee and cola block absorption, so leave 15 minutes between.

📅 The fortnight that decides it

A practical sequence, whichever medication is chosen.

• 📌 Before day 1 — pick a quit date one to two weeks ahead, somewhere not loaded with stress or alcohol. Note when and where cigarettes actually happen for a few days; the list is usually shorter and more predictable than expected
• 💊 Day 1 — start the medication and keep smoking normally. This feels wrong and is correct
• 🏠 Days 1 to 7 — remove ashtrays and lighters, clean the car, decide what replaces the specific moments. Tell the people around you, which costs nothing and measurably helps
• 🚭 Quit day, around day 8 to 14 — nothing more needs to change about the medication
• 🛡️ The first week after — the hardest stretch and where most attempts end. Avoid the heaviest triggers for these seven days specifically, rather than trying to prove something
• 📈 Weeks 2 to 12 — finish the course. Stopping medication early because things are going well is a frequent and avoidable cause of relapse

The trigger inventory is worth doing properly. Most smoking is attached to about five recurring moments — the first coffee, leaving the building, after eating, the phone call, the drink. Each one needs something to occupy the same slot, and deciding that in advance works far better than deciding it while craving.

📊 Weight, honestly

This stops people from trying, so it deserves straight numbers rather than reassurance.

Average weight gain after stopping is around 4 to 5 kg over the first year, most of it in the first three months. It happens for two reasons: nicotine mildly raises metabolic rate and suppresses appetite, and food tastes better once taste and smell recover.

Three things are true at once. The gain is real, it is substantially smaller than most people fear, and the health benefit of stopping outweighs the harm of those kilograms by a very wide margin — including for blood pressure and for diabetes risk, which is where the concern usually comes from. Bupropion blunts the gain while it is being taken, and nicotine replacement delays it.

Practically: do not attempt a diet in the same month. Handle the oral habit with something low in calories, keep moving, and address weight afterwards if it still matters.

💊 The interaction almost nobody is told about

This section is here because it is genuinely important and almost never appears in consumer material.

The caffeine version of this affects everybody. The same number of coffees hits considerably harder after quitting, producing jitteriness, a racing heart and poor sleep — which is then blamed on nicotine withdrawal and sometimes on the medication. Cutting caffeine by roughly a third to a half around the quit date removes a surprising amount of what people experience as withdrawal.

🔄 One cigarette is not the end

The distinction between a lapse and a relapse decides a lot of outcomes.

A lapse is one cigarette. It is extremely common, it does not undo the progress made, and the receptor changes do not reverse from a single exposure. A relapse is returning to regular smoking, and it usually happens because the lapse was interpreted as proof of failure — the reasoning being that the attempt is already ruined, so the packet may as well be finished.

Deciding in advance what happens after a lapse is therefore part of the plan, not pessimism. The answer is: carry on with the medication, work out what the trigger was, and do not change anything else.

It is also worth knowing that most people who stop permanently did not do it on the first attempt. Each attempt teaches something about the specific triggers involved, and previous failures predict very little about the current one — particularly if previous attempts were unmedicated.

🫁 What the body does afterwards

The repair timeline, which is the most motivating thing on this page and the reason it is worth putting the hard fortnight in.

Age changes the arithmetic but never removes the benefit. Stopping before 40 avoids around 90 percent of the excess risk of dying from smoking, and before 30 close to all of it. Stopping at 60 still adds years. There is no point at which it stops being worth doing, including after a diagnosis has already been made — recovery after a heart attack and response to cancer treatment are both better in people who stop.

Breathing gets its own mention. In chronic bronchitis and COPD, stopping smoking is the only intervention shown to slow the ongoing decline in lung function — inhalers relieve symptoms, this changes the trajectory. More on that in our guide to chronic bronchitis. Circulation improves too, which is why it appears in our guide to erectile dysfunction as a vascular warning.

💨 Where vaping fits

A straight answer, since this is now the first thing many people consider.

Evidence does indicate that e-cigarettes help some people stop smoking, in some studies performing better than nicotine replacement. They are considerably less harmful than cigarettes, because the great majority of smoking harm comes from combustion rather than from nicotine.

The qualifications matter as much as the headline. They are not risk-free and the long-term picture is not yet known. They are not licensed as medicines in most places, so strength and quality vary between products. Dual use — vaping and still smoking — delivers very little benefit, and is where many people end up by default. And nobody who does not already smoke should start, which applies especially to young people.

If vaping is the chosen route, the useful framing is the same as for any other aid: it is a step on the way out, with a plan for reducing and stopping it in turn.

📞 When to seek help

Stop the medication and seek medical advice:

• A seizure of any kind while taking bupropion
• A rash, blistering, or swelling of the face, lips or tongue — urgent
• New or worsening agitation, depressed mood, or thoughts of self-harm on either drug
• Chest pain or sudden breathlessness

Speak to a doctor or pharmacist before starting:

• Any history of seizures, epilepsy, bulimia or anorexia — bupropion is contraindicated
• If an antidepressant is already being taken — check the generic name, and never combine two bupropion products
• If clozapine, olanzapine, theophylline or warfarin is being taken — doses may need review when smoking stops
• Pregnancy or breastfeeding — stopping is more important than ever, and the approach differs
• Significant kidney or liver disease, which can require a reduced dose
• A recent heart attack or unstable heart condition

Worth an appointment anyway:

• Nausea on varenicline that does not improve with food — the dose can be lowered rather than the attempt abandoned
• Several failed attempts — usually a sign the medication, the dose or the timing needs changing, not the person
• Persistent cough, breathlessness or coughing blood, whether or not smoking has stopped

❓ Frequently asked questions

📑 Sources and editorial

• Cochrane systematic reviews and network meta-analyses of pharmacological interventions for smoking cessation, including varenicline, bupropion, nicotine replacement and combination therapy
• Cochrane reviews of combination nicotine replacement versus single-form therapy, and of behavioural support added to pharmacotherapy
• EAGLES randomised trial of neuropsychiatric safety of varenicline and bupropion in people with and without psychiatric disorders, and the subsequent regulatory removal of the boxed warning in 2016
• Prescribing information for varenicline, including the titration schedule, quit-date options, extended treatment and management of nausea
• Prescribing information for bupropion sustained release, including the pre-quit loading period, contraindications, seizure risk at recommended doses and the warning against concurrent bupropion products
• Clinical practice guidelines on treating tobacco use and dependence
• Literature on nicotinic receptor upregulation in chronic nicotine exposure and its reversal after cessation
• Studies of the time course of nicotine withdrawal symptoms and of relapse timing within quit attempts
• Evidence on post-cessation weight change and on the effect of bupropion and nicotine replacement on that change
• Pharmacology literature on CYP1A2 induction by tobacco smoke constituents and dose implications for clozapine, olanzapine, theophylline and caffeine on cessation
• Cohort studies of mortality reduction by age at cessation, and organ-specific recovery timelines after stopping
• Reviews and trials of e-cigarettes for smoking cessation, including comparisons with nicotine replacement and findings on dual use
• Related reading: chronic bronchitis, erectile dysfunction as a vascular warning, blood pressure
• Related products: Chantix (Varenicline), Zyban (Bupropion), smoking cessation category
• RXshop Editorial Team — reviewed by Thomas Walsh, MD — Psychiatrist & Mental Health Specialist